New Diagnostic Technology Creates Opportunities for Clinical Laboratories to Help Physicians with Faster, More Accurate Diagnoses

Using monoclonal and polyclonal antibodies to detect only human blood in stool, this technology compares favorably when tested against other methodologies

New diagnostic technologies are literally tumbling out of research laboratories and biotech development companies at an increasing pace. The sheer volume of proprietary medical laboratory tests and new molecular diagnostic assays makes it a challenge for pathologists and clinical laboratory managers to identify which new lab tests have the greatest clinical value—and will also be adequately reimbursed by payers.

Each time a clinical laboratory wants to bring up a new medical laboratory test, it requires substantial effort. The laboratory will expend substantial financial, clinical, and operational resources to acquire the instrumentation, run the studies needed to validate the test, and begin the process of educating physicians about the value of the new test and how to use it in their medical practice. (more…)